Endoscopic Treatment for Portal Hypertension: What’s New in the Last 12 Months?

Introduction

For some 20 years now, endoscopy has been revolutionizing the management of variceal hemorrhage as the most life-threatening sequela of portal hypertension. Portal shunt procedures and decompressive surgery have largely been replaced by endoscopic treatment modalities. However, endoscopic treatment is still a palliative measure, as it does not alter the underlying portal hypertension. Pharmacotherapy and transjugular intrahepatic portosystemic shunting (TIPS) are therefore still indispensable adjuncts for controlling and preventing variceal hemorrhage. Papers published in this field between June 2003 and August 2004 focusing on endoscopic topics are reviewed here.

References

• 1 Avgerinos A, Armonis A, Stefanidis G. et al . Sustained rise of portal pressure after sclerotherapy, but not band ligation, in acute variceal bleeding in cirrhosis.  Hepatology. 2004;  39 1623-1630
• 2 Imazu H, Matsui T, Noguchi R. et al . Magnetic resonance angiography for monitoring prophylactic endoscopic treatment of high risk esophageal varices.  Endoscopy. 2000;  32 766-772
• 3 Lo G H, Chen W C, Chen M H. et al . Endoscopic ligation vs. nadolol in the prevention of first variceal bleeding in patients with cirrhosis.  Gastrointest Endosc. 2004;  59 333-338
• 4 Schepke M, Kleber G, Nurnberg D. et al . Ligation versus propranolol for the primary prophylaxis of variceal bleeding in cirrhosis.  Hepatology. 2004;  40 65-72
• 5 Nakamura S, Mitsunaga A, Murata Y. et al . Endoscopic induction of mucosal fibrosis by argon plasma coagulation (APC) for esophageal varices: a prospective randomized trial of ligation plus APC vs. ligation alone.  Endoscopy. 2001;  33 210-215
• 6 Hino S, Kakutani H, Ikeda K. et al . Low power diode laser treatment using indocyanine green for eradication of esophageal varices.  Endoscopy. 2001;  33 873-875
• 7 Matsui S, Kudo M, Nakaoka R. et al . Comparison of argon plasma coagulation and paravariceal injection sclerotherapy with 1 % polidocanol in mucosa-fibrosing therapy for esophageal varices.  J Gastroenterol. 2004;  39 397-399
• 8 Evrard S, Dumonceau J M, Delhaye M. et al . Endoscopic Histoacryl obliteration vs. propranolol in the prevention of esophagogastric variceal rebleeding: a randomized trial.  Endoscopy. 2003;  35 729-735
• 9 Xu R Y, Liu B, Lin N. Therapeutic effects of endoscopic variceal ligation combined with partial splenic embolization for portal hypertension.  World J Gastroenterol. 2004;  10 1072-1074
• 10 Naga M I, Okasha H H, Foda A R. et al . Detachable Endoloop vs. elastic band ligation for bleeding esophageal varices.  Gastrointest Endosc. 2004;  59 804-809
• 11 Ido K, Yamamoto H, Kawamoto C. et al . Esophageal varices obliterated by photodynamic therapy for coexisting early esophageal carcinoma.  Gastrointest Endosc. 1997;  45 420-423
• 12 Li C Z, Cheng L F, Wang Z Q, Gu Y. Photodynamic therapy of esophageal varices: experimental studies in animal veins, and first clinical cases.  Endoscopy. 2003;  35 1043-1048
• 13 Shibukawa G, Irisawa A, Saito A. et al . Variceal recurrence after endoscopic sclerotherapy associated with the perforating veins in lower esophagus independently.  Hepatogastroenterology. 2004;  51 744-747
• 14 Senjyu S, Nishida H, Sakamoto M. et al . Endoscopic color Doppler ultrasonographic evaluation of recurrent esophagogastric varices following endoscopic injection sclerotherapy.  Hepatol Res. 2003;  26 174-180
• 15 Sato T, Yamazaki K, Toyota J. et al . Perforating veins in recurrent esophageal varices evaluated by endoscopic color Doppler ultrasonography with a galactose-based contrast agent.  J Gastroenterol. 2004;  39 422-428
• 16 Mahadeva S, Bellamy M C, Kessel D. et al . Cost-effectiveness of N-butyl-2-cyanoacrylate (Histoacryl) glue injections versus transjugular intrahepatic portosystemic shunt in the management of acute gastric variceal bleeding.  Am J Gastroenterol. 2003;  98 2688-2693
• 17 Greenwald B D, Caldwell S H, Hespenheide E E. et al . N-2-butyl-cyanoacrylate for bleeding gastric varices: a United States pilot study and cost analysis.  Am J Gastroenterol. 2003;  98 1982-1988
• 18 Rengstorff D S, Binmoeller K F. A pilot study of 2-octyl cyanoacrylate injection for treatment of gastric fundal varices in humans.  Gastrointest Endosc. 2004;  59 553-558
• 19 Kok K, Bond R P, Duncan I C. et al . Distal embolization and local vessel wall ulceration after gastric variceal obliteration with N-butyl-2-cyanoacrylate: a case report and review of the literature.  Endoscopy. 2004;  36 442-446
• 20 Seewald S, Sriram P V, Naga M. et al . Cyanoacrylate glue in gastric variceal bleeding.  Endoscopy. 2002;  34 926-932
• 21 Datta D, Vlavianos P, Alisa A, Westaby D. Use of fibrin glue (Beriplast) in the management of bleeding gastric varices.  Endoscopy. 2003;  35 675-678
• 22 Arakaki Y, Murakami K, Takahashi K. et al . Clinical evaluation of combined endoscopic variceal ligation and sclerotherapy of gastric varices in liver cirrhosis.  Endoscopy. 2003;  35 940-945
• 23 Choi Y H, Yoon C J, Park J H. et al . Balloon-occluded retrograde transvenous obliteration for gastric variceal bleeding: its feasibility compared with transjugular intrahepatic portosystemic shunt.  Korean J Radiol. 2003;  4 109-116
• 24 Kakutani H, Hino S, Ikeda K. et al . Use of the curved linear-array echo endoscope to identify gastrorenal shunts in patients with gastric fundal varices.  Endoscopy. 2004;  36 710-714